Company · CIK 0002088082 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Electra Therapeutics, Inc. · ETRA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 PForm 4 → | Sep 23, 5:35 pm EDT | Carl L GordonDirector, 10% Owner | 1,333,333 | $15.00 | $19,999,995 | 1,758,279 | +314% | |
| Sep 21, 2026 CForm 4 → | Sep 23, 5:35 pm EDT | Carl L GordonDirector, 10% Owner | 5,551,837 | — | — | 758,279 | — | |
| Sep 21, 2026 PForm 4 → | Sep 23, 5:29 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 1,333,333 | $15.00 | $19,999,995 | 1,758,279 | +314% | |
| Sep 21, 2026 CForm 4 → | Sep 23, 5:29 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 5,551,837 | — | — | 758,279 | — | |
| Sep 21, 2026 CForm 4 → | Sep 21, 6:20 pm EDT | Gary S. KoeChief Technical Officer | 63,656 | — | — | 63,656 | — | |
| Sep 21, 2026 CForm 4 → | Sep 21, 6:19 pm EDT | Nancy StaglianoDirector | 255,635 | — | — | 255,635 | — | |
| Sep 21, 2026 CForm 4 → | Sep 21, 6:17 pm EDT | Graham ParryChief Scientific Officer | 85,504 | — | — | 85,504 | — | |
| Sep 21, 2026 CForm 4 → | Sep 21, 6:14 pm EDT | Quehuong (Kathy) DongPresident & CEO, Director | 455,484 | — | — | 455,484 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 CForm 4 → | Sep 23, 5:35 pm EDT | Carl L GordonDirector, 10% Owner | 5,551,837 | — | — | 0 | — | |
| Sep 21, 2026 CForm 4 → | Sep 23, 5:29 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 5,551,837 | — | — | 0 | — | |
| Sep 21, 2026 CForm 4 → | Sep 21, 6:20 pm EDT | Gary S. KoeChief Technical Officer | 63,656 | — | — | 0 | — | |
| Sep 21, 2026 CForm 4 → | Sep 21, 6:19 pm EDT | Nancy StaglianoDirector | 255,635 | — | — | 0 | — | |
| Sep 21, 2026 CForm 4 → | Sep 21, 6:17 pm EDT | Graham ParryChief Scientific Officer | 85,504 | — | — | 0 | — | |
| Sep 21, 2026 CForm 4 → | Sep 21, 6:14 pm EDT | Quehuong (Kathy) DongPresident & CEO, Director | 455,484 | — | — | 0 | — |